LizAI XT -- Artificial Intelligence-Powered Platform for Healthcare Data Management: A Study on Clinical Data Mega-Structure, Semantic Search, and Insights of Sixteen Diseases

TL;DR

LizAI XT is an AI-powered healthcare data management platform that efficiently structures, retrieves, and analyzes large-scale clinical datasets across multiple diseases with high accuracy and privacy compliance.

Contribution

The paper introduces LizAI XT, a novel platform that integrates and structures fragmented clinical data with high accuracy, scalability, and strict privacy controls, enhancing healthcare data management.

Findings

Achieves over 95% accuracy in data structuring

Provides sub-second data retrieval times

Effectively handles complex cases like cancer and COPD

Abstract

AI-powered LizAI XT ensures real-time and accurate mega-structure of different clinical datasets and largely inaccessible and fragmented sources, into one comprehensive table or any designated forms, based on diseases, clinical variables, and/or other defined parameters. We evaluate the platform's performance on a cluster of 4x NVIDIA A30 GPU 24GB, with 16 diseases -- from deathly cancer and COPD, to conventional ones -- ear infections, including a total 16,000 patients, $\sim$115,000 medical files, and $\sim$800 clinical variables. LizAI XT structures data from thousands of files into sets of variables for each disease in one file, achieving >95.0% overall accuracy, while providing exceptional outputs in complicated cases of cancers (99.1%), COPD (98.89%), and asthma (98.12%), without model-overfitting. Data retrieval is sub-second for a variable per patient with a minimal GPU power, which can significantly be improved on more powerful GPUs. LizAI XT uniquely enables fully client-controlled data, complying with strict data security and privacy regulations per region/nation. Our advances complement the existing EMR/EHR, AWS HealthLake, and Google Vertex AI platforms, for healthcare data management and AI development, with large-scalability and expansion at any levels of HMOs, clinics, pharma, and government.